Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training

Summary

Here, we present protocols of high-intensity interval and moderate-intensity continuous exercise to observe the response of circulating cardiac troponin T (cTnT) concentration to acute exercise over 10 days. The information may assist with clinical interpretations of post-exercise cTnT elevation and guide the prescription of exercise.

Abstract

An elevation in cardiac troponin T (cTnT), as a highly specific biomarker of cardiomyocyte damage, after moderate-intensity continuous exercise (MCE) has been described. The exercise-induced cTnT response distorts the diagnostic role of the cTnT assay. Although high-intensity interval exercise (HIE) is growing in popularity and concerns remain about its safety, available data related to cTnT release after HIE is limited, which hampers the use of HIE as a health intervention. Here, we present three representative HIE protocols [traditional HIE (repeated 4 min cycling at 90% V̇O_2max interspersed with 3 min rest, 200 kJ/session); sprint interval exercise (SIE, repeated 1 min cycling at 120% V̇O_2max interspersed with 1.5 min rest, 200 kJ/session); and repeated sprint exercise (RSE, 40 x 6 s all-out sprints interspersed with 9 s rest)] and one representative MCE protocol (continuous cycling exercise at an intensity of 60% V̇O_2max, 200 kJ/session). Forty-seven sedentary, overweight young women were randomly assigned to one of four groups (HIE, SIE, RSE, and MCE). Six bouts of respective exercise were performed by every single group, with each being 48 h apart. Meanwhile, for four groups, the duration of the entire testing period was identical, being 10 days. Before and after the first and final exercise bouts, an assessment was conducted of cTnT. The current study provides a frame of reference giving a clear picture of how a specific exercise session affects the circulating cTnT concentration at the early stage of training. The information may assist with clinical interpretations of post-exercise cTnT elevation and guide the prescription of exercise, especially for HIE.

Introduction

The benefits of regular exercise on the heart are well-documented¹. However, the risk of cardiac events, such as acute myocardial infarction (AMI), transiently increases during an intense exercise^2,3. Individuals with low levels of regular physical activity show higher risk towards AMI^2,3. Cardiac troponin T (cTnT) is the biochemical gold standard in the diagnosis of AMI⁴. However, there is a burgeoning evidence that the cTnT is elevated after continuous prolonged exercise, which undoubtedly distorts the diagnostic role of the cTnT assay⁵.

The repetitive bouts of relatively intense exercise interspersed with short breaks are a typical element of high-intensity interval exercise (HIE), which is growing in popularity in various fields such as cardiac rehabilitation, health and fitness^6,7. The widespread interest in HIE is due in part to the ability of HIE training to elicit beneficial physiological adaptations similar or superior to the traditional moderate-intensity continuous exercise (MCE) training, despite a reduced total exercise volume and time commitment⁶. However, concerns related to the safety of HIE have been expressed due to the high cardiac demand⁸. To date, available data related to cTnT release upon HIE is limited. Moreover, no previous integrated study has investigated the effect of various modalities of HIE and traditional MCE on the appearance of cTnT with exercise. Thus, it is unclear whether, with equalization of total mechanical work between HIE and MCE, different exercise formats will lead to the distinction in cTnT concentrations and what the range of the elevated cTnT values is. Given that exercise conducted at higher intensities might lead to a higher risk of cardiac events^2,3, it is pertinent to develop a representative HIE and MCE proposals with the known range of cTnT responses. The evaluation of exercise-associated cTnT elevation could potentially be helpful in clinical decision-making and assist clinical physiologists in developing more effective and safe exercise prescriptions.

Consequently, we outline protocols of the three representative types of HIE and one representative type of MCE to gather physiological data while observing cTnT responses. Considering that the risk of acute cardiac events is higher in people who do not engage in regular exercise^2,3 and the overall release of cTnT induced by exercise reduces with regular training⁹, this study recruited sedentary, overweight females who completed a 10 day training program. This provided the prospect to work in the early stage of training and target an under-researched group.

Protocol

The protocol (No. 31771319) was approved by the Hebei Normal University Review Board and conformed to the Declaration of Helsinki. All participants provided written informed consent before participating in the testing described.

1. Participant Screening and Preparation for the Experiment

1. For recruitment, ensure that the participants satisfy the following inclusion criteria: aged between 18 and 25, a minimum body mass index (BMI) of 23 kg/m, which is the overweight cut-off for Asian adults¹⁰, consistent body weight (± 2 kg) for the most recent three months, no exercise training or regular physical activities, no record of hormonal, orthopaedic or cardiovascular diseases, diabetes, hyperlipidaemia, hypertension or polycystic ovary syndrome, as well as, no current use of prescribed medications (including contraceptive pills) and no history of smoking.
2. Randomly assign 47 eligible participants to one of the following four groups: traditional HIE (n = 12), sprint interval exercise (SIE, n = 11), repeated sprint exercise (RSE, n = 12) or MCE (n = 12) group.
3. Adjust and record the appropriate seat height on the cycling ergometers so that the participant pedals with a slight knee bend (~10°) at full downstroke of the pedal.
4. Instruct the participants to perform two initial exercise sessions (as described in step 3) to familiarize them with the respective type of cycling exercise (HIE, SIE, RSE or MCE).

2. Experimental Procedures

1. First, instruct each participant to perform a continuous incremental test on a stress testing cycle ergometer to assess maximal oxygen uptake (V̇O_2max).
   1. Warm up for 5 min at 25 W. Then start the test by performing continuous 2 min stages (20 W increment per stage) starting at 50 W with a pedal frequency of 60 rpm until volitional exhaustion.
   2. Use a breath-by-breath metabolic analyzer to measure the oxygen consumption during the exercise.
   3. Calculate the V̇O_2max based on the highest 30 s average value. Then, calculate a power output that elicits 60%, 90% and 120% V̇O_2max in the MCE, HIE and SIE groups, respectively, using the equation of linear regression through plotting the steady state V̇O2 versus power output¹¹.
2. At least 5 days after pre-intervention assessments, instruct the HIE, SIE, RSE and MCE groups to commence their respective training.
   NOTE: Start all exercise tests at the same time of the day (e.g., 11:00 A.M.). Meanwhile, ensure that the tests are conducted in a laboratory with temperature and humidity-controlled settings (20 °C and 50% relative humidity). Ask all participants to stick to both their daily activities and eating habits throughout the experiment.
   1. Instruct the participant to refrain from any strenuous exercise for 48 h, after a routine warm-up, instruct the HIE, SIE, RSE and MCE groups to engage in their respective exercise session on a cycle ergometer as arranged. Perform the exercise protocol as detailed in step 3.
   2. Perform 6 exercise sessions carried out over a time span of 10 days for all four groups. Select the 1^st (1ST) and 6^th (6TH) exercise sessions to observe the cTnT response to the acute exercise (Figure 1).

Figure 1: Schematic diagram of study procedures. HIE = high-intensity interval exercise; SIE = sprint interval exercise; RSE = repeated sprint exercise; MCE = moderate-intensity continuous exercise. Please click here to view a larger version of this figure.

4. Record a continuous electrocardiogram (ECG) during exercise via a portable electrocardiograph (ECG) monitor.
5. Draw venous blood samples before and immediately after exercise, as well as 3 h and 4 h after the selected exercise session to assess the serum cTnT. With the subjects in a seated position, draw 5 mL of venous blood from the antecubital vein for each sample.
   NOTE: Post-exercise blood samples timings conformed to our prior work, which demonstrated that blood cTnT concentrations reached their peak 3 or 4 h following acute exercise in a laboratory-based study¹².
6. For the separation of the serum, allow the blood to clot at room temperature. Centrifuge the blood samples at 3,500 x g for 20 min.
7. Aspirate the serum and store at -80 °C for the subsequent analysis of cTnT.
8. Use an analyzer to perform the quantitative measurement of the cTnT with a high sensitivity immunoassay based on electrochemiluminescence technology. Take 1 mL of the serum and put it into a special test tube for measuring cTnT. Then insert the tube in the analyzer and press the start button.
   NOTE: The human cTnT protein itself consists of 288 amino acids. Two monoclonal antibodies are used for the assay which are specifically directed against human cardiac troponin T. The antibodies recognize the central part of cardiac troponin T protein⁴, specifically targeting two epitopes at amino acid positions 125-131 and 136-147.

3. Exercise Protocols

1. In each exercise session, instruct the 4 groups to follow the steps below.
   1. Complete an identical 10 min warm-up at 50-60% of HR_max (percentage of individual maximal heart rate during exercise session) and 5 min cool down at 20 W.
   2. Following the warm-up. Have a 2 min recovery period, where participants remain seated but stationary on the cycle ergometer.
   3. Direct the participants to accelerate as soon as possible at the beginning of each exercise bout to reach the intended intensity. During this time a researcher sets the respective exercise protocol in a PC computer and then counts down, "5-4-3-2-1-Go!". At the command of "Go!", participants start to exercise and activate the computerized system.
      NOTE: For the MCE, HIE and SIE, accelerate to the planned intensity (see step 2.1.3), i.e. 60%, 90% and 120% V̇O_2max, respectively. For the RSE, accelerate to “all-out” exercise (see step 3.4). The ergometer is linked to a PC computer with specific software.
   4. Instruct the participants to remain seated while cycling and secure their feet to the pedals using toe clips, and verbally encourage the participants to give a maximal effort to exercise at the desired intensity throughout each session.
2. HIE protocol: Repeat 4 min bouts of exercise on a stress testing cycle ergometer at an intensity of 90% V̇O_2max, followed by a 3 min passive recovery (complete rest) until the targeted 200 kJ of work is achieved.
3. SIE protocol: Repeat 1 min bouts of exercise on a stress testing cycle ergometer at an intensity of 120% of V̇O_2max, followed by a 1.5 min passive recovery until the targeted 200 kJ of work is achieved.
4. RSE protocol: Repeat 6 s “all-out” sprints interspersed with 9 s passive recovery periods on a Wingate testing cycle ergometer, with a resistance of 1.0 kg until the targeted 40 repetitions are achieved, and the total mechanical work was recorded.
5. MCE protocol: Perform continuous cycling exercise, until a target of 200 kJ of work is achieved, at an intensity of 60% V̇O_2max.

4. Statistical Analyses

1. Perform data analysis using a statistical software package. Evaluate the normality of the data using the Kolmogorov–Smirnov test¹². Use P < 0.05 for assessing statistical significance.
2. Compare the differences in HR_mean (mean heart rate during exercise session) and %HR_max across the four groups (HIE, SIE, RSE and MCE) and the two observed exercise sessions (1ST and 6TH) using two-way ANOVA, with repeated measures. Use the Newman–Keuls post-hoc test for cases in which the main effect is significant.
3. Compare cTnT across the time points (pre-exercise and peak post-exercise) and two observed exercise sessions (1ST and 6TH) using the non-parametric Wilcoxon signed ranks test because of the skewed distribution of the cTnT data. Further, the Kruskal-Wallis test was used to assess the statistical significance of differences in cTnT levels across the four groups (HIE, SIE, RSE and MCE), and the Mann-Whitney U test was used for pairwise comparisons where appropriate.

Results

All participants (n = 47) completed the study, and no adverse cardiac events (e.g., chest pain and sign of myocardial ischemia on ECG) were found during testing in the four groups. As expected, the acute exercise heart rate (HR) data, including HR_mean and %HR_max, at the 1ST assessment is similar (all P > 0.05) to those in the 6TH assessment in all four groups. Further, the HR data in the RSE and MCE groups is the highest and lowest among the four groups, respectively, but is similar betw...

Discussion

The repetitive short to long bouts of rather high-intensity exercise interspersed with recovery periods are involved in HIE, which is subdivided into traditional HIE (“near maximal” efforts) and SIE (“supramaximal” efforts), using a common classification scheme⁶. In addition, RSE is a particularly intense form of SIE, where the activity is “all-out” but only lasts for 3 to 7 s⁶. To the best of our knowledge, this is the first integrated s...

Materials

List of materials used in this article

Name	Company	Catalog Number	Comments
Cobas E 601 analyser	Roche Diagnostics, Penzberg, Germany		Used for measuring the circulating cardiac troponin T concentration
Monark 839E Stress Testing Cycle Ergometer	Monark Exercise AB, Vansbro, Sweden		Used for all exercise protocols except repeated sprint exercise
Monark 894E Wingate Testing Cycle Ergometer	Monark Exercise AB, Vansbro, Sweden		Only used for repeated sprint exercise protocol
Quark-PFT-ergo Metabolic Analyser	Cosmed, Rome, Italy	C09072-02-99
SPSS Statistics 20.0 software package	IBM Corp., Armonk, USA
Zephyr BioHarness 3.0	Zephyr Technology, Auckland, New Zealand	9800.0189/9600.0190	Electrocardiograph Monitor